Novartis Expects Q3 Core Operating Income in Line to Low-Single-Digit Growth
Novartis revised its expectation for Q3 core operating income from a low-single-digit decline to in-line performance or low-single-digit growth.
Novartis revised its expectation for Q3 core operating income from a low-single-digit decline to in-line performance or low-single-digit growth.